🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II trial to assess whether IRESSA™ (gefitinib) has anti-tum...
Status
Completed
Location
Multiple Locations
Start Date
2001-04
Trial ID
NCT00632723
Treatments Being Tested
1. Gefitinib CTTQ production gefitinib and erlotinib sheet AstraZeneca imat...
Status
Unknown
Location
Multiple Locations
Start Date
2017-08
Trial ID
NCT03264794
The study design is an Open-Label，Randomized, Single-Dose, 2-way Crossover ...
Status
Completed
Location
Multiple Locations
Start Date
2016-09-01
Trial ID
NCT03050177
Treatments Being Tested
The purpose of this study is to provide ZD1839 for those patients with loca...
Status
Approved For Marketing
Location
Research Site
Start Date
TBD
Trial ID
NCT00684385
Treatments Being Tested
This is an open-label phase 1, safety, PK, and preliminary efficacy study o...
Status
Completed
Location
Gustave Roussy
Start Date
2014-01
Trial ID
NCT02040064
Treatments Being Tested
This study assessed the safety and efficacy of escalating doses INC280 when...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-04-05
Trial ID
NCT01610336
This is a double blind, multicentre, randomized, placebo-controlled study. ...
Status
Completed
Location
Research Site
Start Date
2008-09
Trial ID
NCT00770588
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), in...
Status
Unknown
Location
Peking University Third Hospital
Start Date
2016-05
Trial ID
NCT03050411
Treatments Being Tested
The investigators performed a randomized, double blind controlled, prospect...
Status
Completed
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT02889692
Treatments Being Tested
This is a multinational, multicenter, randomized, open-label, Phase 3 study...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-09
Trial ID
NCT01774721
Treatments Being Tested